CV Sciences (CV Sciences) Capital Expenditure : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is CV Sciences Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

CV Sciences's cash flow for capital expenditures for the three months ended in Mar. 2024 was $0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

CV Sciences Capital Expenditure Historical Data

The historical data trend for CV Sciences's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences Capital Expenditure Chart

CV Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-1.15

-1.06

-0.04

CV Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capital Expenditure	Get a 7-Day Free Trial															-	-	-	-	-

CV Sciences Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

CV Sciences (CV Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

0HRT:UK

Address

9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126

Website

https://www.cvsciences.com

CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.

Executives

William Mccorkle	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr.	director	9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md	director	2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake	director	145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay	officer: Sr VP Scientific/Regulatory	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling	officer: Chief Financial Officer	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser	officer: CFO	2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham	director	C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty	director	C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin	director	1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc.	other: Member 10% holding group	6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118